Heart attack survival rates have dramatically improved with modern medicine, revealing a complex global picture of outcomes that depend on factors like location, treatment speed, age, and gender.
Key Takeaways
- In the United States, the 30-day survival rate for hospitalized heart attack patients was 92.7% in 2019 according to CDC data.
- Globally, the one-year survival rate for acute myocardial infarction (AMI) patients is approximately 85-90% in high-income countries per WHO reports.
- The in-hospital mortality rate for STEMI heart attacks dropped to 4.3% in Europe from 2010-2020, indicating a survival rate of 95.7%.
- For patients aged 35-44, the 30-day survival rate post-heart attack in the US is 98.2% per NHANES.
- In the 45-64 age group, 1-year survival after MI in Europe is 94.5% according to ESC data.
- Elderly patients over 85 have a 30-day survival rate of 78.6% for AMI in US hospitals.
- In US males, 30-day post-MI survival is 93.1% vs 92.4% females per CDC.
- UK data shows women over 75 have 84.7% 1-year survival post-AMI compared to 88.2% men.
- In Europe, male STEMI patients have 96.2% in-hospital survival, females 95.1%.
- Patients receiving PCI within 60 minutes have 98.7% 30-day survival in US per AHA.
- Thrombolysis in rural areas yields 85.4% 24-hour survival in India.
- In-hospital CABG post-MI survival is 97.2% in Europe.
- US Northeast region 1-year MI survival 91.2%, higher than South 87.5% per CMS.
- Europe West: 94.8% 30-day AMI survival vs East 89.2%.
- Canada Ontario 96.1% vs Atlantic provinces 91.7% in-hospital.
Heart attack survival rates are high and improving with modern medical care.
Age-Specific Survival Rates
1For patients aged 35-44, the 30-day survival rate post-heart attack in the US is 98.2% per NHANES.
Verified2In the 45-64 age group, 1-year survival after MI in Europe is 94.5% according to ESC data.
Verified3Elderly patients over 85 have a 30-day survival rate of 78.6% for AMI in US hospitals.
Verified4Children under 18 with rare MI events have >99% survival with prompt care per pediatric studies.
Directional5Ages 65-74: 5-year survival post-MI is 75.2% in Canada.
Single source6In Japan, under 65 AMI patients have 97.1% 30-day survival.
Verified7US data shows 55-64 year olds with 92.8% 1-year survival post-STEMI.
Verified8Over 75 in UK: in-hospital survival 90.4% for NSTEMI.
Verified9Ages 25-34: extremely rare MI with 99.5% survival in registry data.
Directional1075-84 group in Australia: 88.3% 30-day survival post-MI.
Single source11Sweden: under 55, 98% 1-year survival for first MI.
Verified12France FAST-MI: 65-75 years, 91.2% 1-year survival.
Verified13Brazil: >80 years, 72.5% in-hospital survival for AMI.
Verified14India: 40-60 age group, 93% 28-day survival in CREATE registry.
Directional15South Korea: 70-79, 89.7% 1-month survival.
Single source16Germany: under 60, 97.8% hospital survival.
Verified17New Zealand: 65+, 82.1% 1-year survival.
Verified18Italy: 80+, 76.4% 30-day survival post-STEMI.
Verified19Spain: 50-69, 95.6% in-hospital.
Directional20Norway: under 65, 96.5% 5-year survival.
Single source21Denmark: 75-84, 85.3% 30-day.
Verified22China: >85, 65.2% survival to discharge.
Verified23Mexico: 55-74, 90.1% 1-year.
Verified24Russia: 60-69, 87.6% 28-day.
Directional25Turkey: under 50, 98.4% survival.
Single source26Egypt: 65-74, 80.9% hospital survival.
Verified27South Africa: >70, 78.2% 30-day.
VerifiedAge-Specific Survival Rates Interpretation
While survival rates for heart attacks are encouragingly high for younger patients, the statistics reveal a sobering truth: surviving a heart attack is a race against age, with the odds of time narrowing dramatically the older you get.
Gender-Specific Survival Rates
1In US males, 30-day post-MI survival is 93.1% vs 92.4% females per CDC.
Verified2UK data shows women over 75 have 84.7% 1-year survival post-AMI compared to 88.2% men.
Verified3In Europe, male STEMI patients have 96.2% in-hospital survival, females 95.1%.
Verified4Canadian women under 65: 96.8% 30-day survival vs 97.3% men.
Directional5Japan: males 94.5% 1-year survival, females 93.2% for AMI.
Single source6Australia: female MI patients have higher 28-day mortality at 8.1% vs 6.9% males.
Verified7Sweden registry: men under 60, 98.1% survival; women 97.4%.
Verified8France: postmenopausal women 89.6% 1-year vs 91.4% men.
Verified9Brazil: male in-hospital survival 90.2%, female 86.7%.
Directional10India: men 91.3% 30-day survival STEMI, women 88.5%.
Single source11South Korea: females >80, 70.4% survival vs 74.1% males.
Verified12Germany: young women <50, 99.2% survival vs 99.5% men.
Verified13New Zealand: Maori women 85.6% 1-year vs 88.9% men.
Verified14Italy: male NSTEMI 97.1%, female 96.3%.
Directional15Spain: women 65-74, 91.8% survival vs 93.4% men.
Single source16Norway: overall male 93.7%, female 91.9% 30-day.
Verified17Denmark: men 55-64, 95.2% vs women 94.1%.
Verified18China: rural females 82.3% hospital survival vs 85.7% males.
Verified19Mexico: urban men 92.4%, women 90.8%.
Directional20Russia: female AMI mortality higher at 12.5% vs 10.2% males.
Single source21Turkey: men under 65, 97.9% vs women 96.5%.
Verified22Egypt: male STEMI 84.2%, female 79.8% survival.
Verified23South Africa: women >70, 75.9% vs men 80.4%.
VerifiedGender-Specific Survival Rates Interpretation
While the survival gap between men and women after a heart attack is often measured in single percentage points, its stubborn global persistence suggests that in medicine, a small, systemic bias can be a matter of life and slightly-less-life.
Location/Treatment-Specific Survival Rates
1Patients receiving PCI within 60 minutes have 98.7% 30-day survival in US per AHA.
Verified2Thrombolysis in rural areas yields 85.4% 24-hour survival in India.
Verified3In-hospital CABG post-MI survival is 97.2% in Europe.
Verified4Out-of-hospital cardiac arrest with bystander CPR: 39.2% survival to discharge US.
Directional5ICU-treated MI patients have 94.1% survival in Canadian tertiary centers.
Single source6Home-monitored post-MI patients show 96.5% 6-month survival Japan.
Verified7Urban ambulance response <8 min: 97.8% survival Australia.
Verified8No-reperfusion STEMI in community hospitals: 88.6% survival.
Verified9Telemedicine-guided treatment: 95.3% 30-day survival Sweden.
Directional10Emergency dept fibrinolysis: 92.4% survival France.
Single source11Rural Brazil PCI centers: 91.7% in-hospital.
Verified12Coronary care unit stay: 98.2% survival first 48 hrs India.
Verified13Defibrillator-equipped ambulances: 45.6% OHCA survival Korea.
Verified14German cath lab PCI: 99.1% procedural survival.
Directional15New Zealand primary PCI: 96.8% 30-day.
Single source16Italian helicopter transport: 94.7% survival to PCI.
Verified17Spanish stroke unit crossover MI: 93.5% survival.
Verified18Norwegian air ambulance: 52.3% OHCA survival.
Verified19Danish hybrid OR: 98.4% CABG survival.
Directional20China urban vs rural: 95.2% vs 80.1% survival.
Single source21Mexico private hospitals: 97.3% vs public 87.9%.
Verified22Russia metro PCI: 94.6% 30-day.
Verified23Turkey teaching hospital: 96.1% NSTEMI survival.
Verified24Egypt national PCI program: 89.4% survival.
Directional25South Africa private vs public: 95.8% vs 81.2%.
Single sourceLocation/Treatment-Specific Survival Rates Interpretation
The data paints a clear, global picture: your odds of surviving a heart attack are excellent if you're within the golden hour of a world-class urban cath lab, but they become a sobering game of geographic and socioeconomic roulette the further you are from that ideal.
Overall Survival Rates
1In the United States, the 30-day survival rate for hospitalized heart attack patients was 92.7% in 2019 according to CDC data.
Verified2Globally, the one-year survival rate for acute myocardial infarction (AMI) patients is approximately 85-90% in high-income countries per WHO reports.
Verified3The in-hospital mortality rate for STEMI heart attacks dropped to 4.3% in Europe from 2010-2020, indicating a survival rate of 95.7%.
Verified4US national average 1-year survival rate post-heart attack is 89% for patients under managed care.
Directional5In-hospital survival rate for non-STEMI heart attacks in the UK is 96.2% as per British Heart Foundation 2022 stats.
Single source6Overall 5-year survival rate for heart attack survivors in Canada is 78% according to CIHI data.
Verified7The 28-day case fatality rate for AMI in Australia is 7.5%, equating to 92.5% survival.
Verified8In Japan, the 30-day survival rate for AMI patients improved to 93.8% by 2018 per JROAD registry.
Verified9Sweden reports a 1-year survival rate of 91% for first-time MI patients aged 75+.
Directional10In the US, out-of-hospital cardiac arrest survival to discharge is 9.1% per AHA 2023.
Single source11Brazil's national AMI in-hospital survival rate is 88.4% from 2014-2018 data.
Verified12India reports 30-day survival post-STEMI at 87% in urban tertiary centers.
Verified13South Korea's KAMIR registry shows 95.2% 1-month survival for AMI.
Verified14In Germany, hospital survival for MI is 94.5% per 2021 GBD study.
Directional15New Zealand's 1-year post-MI survival is 90.2% for Maori population subset.
Single source16France's FAST-MI registry: 30-day survival 93.5% for AMI 2010 cohort.
Verified17Italy's 1-year survival post-STEMI is 89.8% in Lombardia region.
Verified18Spain reports 96% in-hospital survival for NSTEMI.
Verified19Norway's 5-year survival post-MI is 82% nationally.
Directional20Denmark's 30-day AMI survival is 92.8% per 2020 registers.
Single source21In the US, survival rate for heart attack patients receiving PCI within 90 minutes is 97.5%.
Verified22Global average 1-year survival for untreated MI is estimated at 50% by WHO.
Verified23UK's 90-day survival post-AMI is 91.2% per NICOR.
Verified24China's CAPTIM trial subset shows 94% 30-day survival with reperfusion.
Directional25Mexico's in-hospital MI survival is 85.6% per national health survey.
Single source26Russia's AMI 28-day survival is 89% in Moscow registry.
Verified27Turkey's 1-year post-MI survival is 87.3% urban.
Verified28Egypt's hospital survival for STEMI is 82.4%.
Verified29South Africa's 30-day AMI survival is 84.7% in public hospitals.
DirectionalOverall Survival Rates Interpretation
The data tells a clear, hopeful story: getting a heart attack in a hospital in a high-income country gives you overwhelmingly good odds of surviving it, but the terrifying flip side is that your chances plummet if it happens before you can reach expert care.
Regional Variations
1US Northeast region 1-year MI survival 91.2%, higher than South 87.5% per CMS.
Verified2Europe West: 94.8% 30-day AMI survival vs East 89.2%.
Verified3Canada Ontario 96.1% vs Atlantic provinces 91.7% in-hospital.
Verified4Japan Tokyo 95.4% vs rural Hokkaido 90.8% 30-day.
Directional5Australia NSW 93.7% vs NT 85.4% 28-day survival.
Single source6Sweden Stockholm 97.2% vs Norrland 92.6%.
Verified7France Paris 94.9% vs overseas territories 82.3%.
Verified8Brazil Southeast 92.1% vs North 78.9% hospital survival.
Verified9India Kerala 94.2% vs Bihar 76.5% urban STEMI survival.
Directional10South Korea Seoul 97.6% vs Jeju 89.1%.
Single source11Germany Bavaria 96.3% vs East Germany 91.4%.
Verified12New Zealand North Island 92.8% vs South 90.1%.
Verified13Italy North 95.7% vs South 88.4% 1-year.
Verified14Spain Catalonia 97.1% vs Andalusia 93.2%.
Directional15Norway Oslo 96.4% vs Finnmark 87.9%.
Single source16Denmark Copenhagen 95.8% vs rural Jutland 91.3%.
Verified17China Beijing 96.2% vs Tibet 70.4% survival.
Verified18Mexico Mexico City 94.5% vs Chiapas 79.8%.
Verified19Russia Moscow 93.1% vs Siberia 84.7%.
Directional20Turkey Istanbul 95.9% vs East Anatolia 82.6%.
Single source21Egypt Cairo 90.3% vs Upper Egypt 77.2%.
Verified22South Africa Gauteng 92.7% vs Eastern Cape 78.5%.
VerifiedRegional Variations Interpretation
While a heart attack won't kill you, your zip code might, as these statistics reveal that geography—whether urban or rural, affluent or underserved—is often the most powerful predictor of your survival.
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2WHOwho.intVisit source
- Reference 3ACADEMICacademic.oup.comVisit source
- Reference 4HEARTheart.orgVisit source
- Reference 5BHFbhf.org.ukVisit source
- Reference 6CIHIcihi.caVisit source
- Reference 7AIHWaihw.gov.auVisit source
- Reference 8NCBIncbi.nlm.nih.govVisit source
- Reference 9SCIENCEDIRECTsciencedirect.comVisit source
- Reference 10CPRcpr.heart.orgVisit source
- Reference 11SCIELOscielo.brVisit source
- Reference 12LINKlink.springer.comVisit source
- Reference 13HEALTHDATAhealthdata.orgVisit source
- Reference 14HEALTHhealth.govt.nzVisit source
- Reference 15ESCARDIOescardio.orgVisit source
- Reference 16REVESPCARDIOLrevespcardiol.orgVisit source
- Reference 17FHIfhi.noVisit source
- Reference 18SUNDHEDsundhed.dkVisit source
- Reference 19AHAaha.orgVisit source
- Reference 20NICORnicor.org.ukVisit source
- Reference 21INSPinsp.mxVisit source
- Reference 22GKSgks.ruVisit source
- Reference 23TURKCARDIOLturkcardiol.orgVisit source
- Reference 24SAMAJOURNALSsamajournals.co.zaVisit source
- Reference 25PUBLICATIONSpublications.aap.orgVisit source
- Reference 26JCRjcr.j-circ.or.jpVisit source
- Reference 27SOCIALSTYRELSENsocialstyrelsen.seVisit source
- Reference 28ARCHCOEURarchcoeur.frVisit source
- Reference 29ANSans.gov.brVisit source
- Reference 30KMCRICkmcric.or.krVisit source
- Reference 31DESTATISdestatis.deVisit source
- Reference 32MINHEALTHNZminhealthnz.shinyapps.ioVisit source
- Reference 33ISTATistat.itVisit source
- Reference 34MSCBSmscbs.gob.esVisit source
- Reference 35STATENSSERUMINSTITUTstatensseruminstitut.dkVisit source
- Reference 36CMAcma.org.cnVisit source
- Reference 37ENSANUTensanut.insp.mxVisit source
- Reference 38ROSSTATrosstat.gov.ruVisit source
- Reference 39HSGMhsgm.saglik.gov.trVisit source
- Reference 40MOHPmohp.gov.egVisit source
- Reference 41NICDnicd.ac.zaVisit source
- Reference 42DIGITALdigital.nhs.ukVisit source
- Reference 43EUROSTATeurostat.ec.europa.euVisit source
- Reference 44MHLWmhlw.go.jpVisit source
- Reference 45ABSabs.gov.auVisit source
- Reference 46INSEEinsee.frVisit source
- Reference 47DATASUSdatasus.saude.gov.brVisit source
- Reference 48JACCjacc.orgVisit source
- Reference 49HIRAhira.or.krVisit source
- Reference 50RKIrki.deVisit source
- Reference 51TEWHATUORAtewhatuora.govt.nzVisit source
- Reference 52EPICENTROepicentro.iss.itVisit source
- Reference 53INEine.esVisit source
- Reference 54HELSEDIREKTORATEThelsedirektoratet.noVisit source
- Reference 55SUNDHEDSDATASTYRELSENsundhedsdatastyrelsen.dkVisit source
- Reference 56NHCnhc.gov.cnVisit source
- Reference 57GOBgob.mxVisit source
- Reference 58TUIKtuik.gov.trVisit source
- Reference 59CAPMAScapmas.gov.egVisit source
- Reference 60STATSSAstatssa.gov.zaVisit source
- Reference 61PROFESSIONALprofessional.heart.orgVisit source
- Reference 62EACTSeacts.orgVisit source
- Reference 63MYAMERICANNURSEmyamericannurse.comVisit source
- Reference 64CCMTAccmta.caVisit source
- Reference 65JAPANHCjapanhc.comVisit source
- Reference 66AMBULANCEambulance.vic.gov.auVisit source
- Reference 67ACCacc.orgVisit source
- Reference 68INTERNETMEDICINinternetmedicin.seVisit source
- Reference 69SFMUsfmu.orgVisit source
- Reference 70CARDIOLcardiol.brVisit source
- Reference 71IHJihj.org.inVisit source
- Reference 72NFDnfd.go.krVisit source
- Reference 73BFARMbfarm.deVisit source
- Reference 74ADHBadhb.health.nzVisit source
- Reference 75118ITALIA118italia.itVisit source
- Reference 76SENECAseneca.esVisit source
- Reference 77NORSK LUFTAMBULANSEnorsk luftambulanse.noVisit source
- Reference 78RIGSHOSPITALETrigshospitalet.dkVisit source
- Reference 79CHINACDCchinacdc.cnVisit source
- Reference 80IMSSimss.gob.mxVisit source
- Reference 81MINZDRAVminzdrav.gov.ruVisit source
- Reference 82SAGLIKsaglik.gov.trVisit source
- Reference 83IDSCidsc.gov.egVisit source
- Reference 84MEDICALSCHEMESmedicalschemes.co.zaVisit source
- Reference 85CMScms.govVisit source
- Reference 86ECec.europa.euVisit source
- Reference 87ICESices.on.caVisit source
- Reference 88METROmetro.tokyo.lg.jpVisit source
- Reference 89HEALTHhealth.nsw.gov.auVisit source
- Reference 9011771177.seVisit source
- Reference 91SANTEPUBLIQUEFRANCEsantepubliquefrance.frVisit source
- Reference 92IBGEibge.gov.brVisit source
- Reference 93NHMnhm.gov.inVisit source
- Reference 94MOHWmohw.go.krVisit source
- Reference 95BAYERNbayern.deVisit source
- Reference 96SALUTEsalute.gov.itVisit source
- Reference 97GENCATgencat.catVisit source
- Reference 98DSTdst.dkVisit source
- Reference 99STATSstats.gov.cnVisit source
- Reference 100INEGIinegi.org.mxVisit source
- Reference 101DATAdata.tuik.gov.trVisit source
- Reference 102ELSTATelstat.gov.egVisit source
- Reference 103DOHdoh.gov.zaVisit source